Itumay, Anita L.

HRN: 05-62-96  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/08/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
08/08/2025
08/15/2025
IV
2.25g
Q8
NONHEALING WOUND
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines